Shelter Pharma Ltd Secures Work Order from Verka Dairies

Shelter Pharma Limited announced it has secured a significant one-year work order from Verka Dairies, a major North Indian dairy company, to supply veterinary medicines. The contract, which can be extended by mutual consent, is expected to boost the company's order book and strengthen its market presence.

Contract Details

Shelter Pharma received the work order for supplying veterinary medicines based on a rate contract.

Key terms include:

• Duration: One year, with an option for extension up to three months.
• Payment: 15 days after material receipt and inspection.
• Delivery: Within 30 days of receiving a purchase order.

Significance of the Contract

This contract highlights Shelter Pharma's ability to secure business from large, reputable organizations.

The agreement is anticipated to positively impact the company's order book and future revenue projections.

Company's Strategic Growth

Shelter Pharma has been focusing on expanding its veterinary division.

In late 2023, the company secured a tender from the Government of Goa for veterinary medicines, indicating its growing footprint in this sector.

Order Value Uncertainty

A primary risk associated with this order is its indeterminate value. The actual revenue generated will depend on the specific quantities Verka Dairies orders throughout the contract period.

Competitive Landscape

Shelter Pharma competes in the veterinary medicine space with companies such as Hester Biosciences, which specializes in poultry vaccines and animal health.

Diversified pharmaceutical firms like Zydus Lifesciences also operate in this market.

Investor Outlook

Investors will be watching the actual order volumes placed by Verka Dairies, as well as Shelter Pharma's efficiency in delivery and execution.

Future contract renewals or extensions will also be a key factor to monitor.